134 related articles for article (PubMed ID: 36427771)
1. Drug-based therapy for advanced adenoid cystic carcinoma: Current landscape and challenges based on an overview of registered clinical trials.
Wagner VP; Ferrarotto R; Vargas PA; Martins MD; Bingle CD; Bingle L
Crit Rev Oncol Hematol; 2023 Jan; 181():103886. PubMed ID: 36427771
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract.
Locati LD; Cavalieri S; Bergamini C; Resteghini C; Alfieri S; Calareso G; Bossi P; Perrone F; Tamborini E; Quattrone P; Granata R; Galbiati D; Platini F; Orlandi E; Mariani L; Licitra L
Head Neck; 2019 Oct; 41(10):3670-3676. PubMed ID: 31355973
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
[TBL] [Abstract][Full Text] [Related]
4. Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.
Locati LD; Galbiati D; Calareso G; Alfieri S; Singer S; Cavalieri S; Bergamini C; Bossi P; Orlandi E; Resteghini C; Platini F; Granata R; Quattrone P; Mancinelli M; Mariani L; Lo Vullo S; Licitra LF
Cancer; 2020 Jan; 126(9):1888-1894. PubMed ID: 32031693
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of gefitinib in patients with advanced salivary gland cancers.
Jakob JA; Kies MS; Glisson BS; Kupferman ME; Liu DD; Lee JJ; El-Naggar AK; Gonzalez-Angulo AM; Blumenschein GR
Head Neck; 2015 May; 37(5):644-9. PubMed ID: 24585506
[TBL] [Abstract][Full Text] [Related]
6. Systemic and Targeted Therapies in Adenoid Cystic Carcinoma.
Kacew AJ; Hanna GJ
Curr Treat Options Oncol; 2023 Jan; 24(1):45-60. PubMed ID: 36637743
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
Chau NG; Hotte SJ; Chen EX; Chin SF; Turner S; Wang L; Siu LL
Ann Oncol; 2012 Jun; 23(6):1562-70. PubMed ID: 22080184
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.
Ho AL; Dunn L; Sherman EJ; Fury MG; Baxi SS; Chandramohan R; Dogan S; Morris LG; Cullen GD; Haque S; Sima CS; Ni A; Antonescu CR; Katabi N; Pfister DG
Ann Oncol; 2016 Oct; 27(10):1902-8. PubMed ID: 27566443
[TBL] [Abstract][Full Text] [Related]
11. Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma.
Kang EJ; Ahn MJ; Ock CY; Lee KW; Kwon JH; Yang Y; Choi YH; Kim MK; Ji JH; Yun T; Nam BH; Kim SB; Keam B
Clin Cancer Res; 2021 Oct; 27(19):5272-5279. PubMed ID: 34315722
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients.
Couvreur K; Celine J; Marlies B; Randal D; Philippe D; Frederic D; Sylvie R
Acta Clin Belg; 2020 Oct; 75(5):362-369. PubMed ID: 31232197
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma.
Kim DH; Lim Y; Ock CY; Park G; Park S; Song H; Ma M; Mostafavi M; Kang EJ; Ahn MJ; Lee KW; Kwon JH; Yang Y; Choi YH; Kim MK; Ji JH; Yun T; Kim SB; Keam B
Head Neck; 2023 Dec; 45(12):3086-3095. PubMed ID: 37828867
[TBL] [Abstract][Full Text] [Related]
14. Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland.
Krucoff KB; Shammas RL; Stoecker M; Tolnitch LA
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30068574
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
17. Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.
Tchekmedyian V; Sherman EJ; Dunn L; Tran C; Baxi S; Katabi N; Antonescu CR; Ostrovnaya I; Haque SS; Pfister DG; Ho AL
J Clin Oncol; 2019 Jun; 37(18):1529-1537. PubMed ID: 30939095
[TBL] [Abstract][Full Text] [Related]
18. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG
Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.
Hoover AC; Milhem MM; Anderson CM; Sun W; Smith BJ; Hoffman HT; Buatti JM
Head Neck; 2015 May; 37(5):722-6. PubMed ID: 24596143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
